— Know what they know.
Not Investment Advice

ANVS NYSE

Annovis Bio, Inc.
1W: -9.9% 1M: -30.6% 3M: -40.1% YTD: -67.7% 1Y: -44.6% 3Y: -87.5% 5Y: -96.6%
$1.18
+0.01 (+0.85%)
 
Weekly Expected Move ±10.6%
$1 $1 $1 $1 $1
NYSE · Healthcare · Biotechnology · Tech Score Sell · Power 33 · $50.2M mcap · 38M float · 2.56% daily turnover · Short 59% of daily vol

Supply Chain Overview

4 relationships
4
As Filer
counterparties named
0
As Counterparty
mentioned by others
3
Rel. Types
2023-04-03
Earliest Filing
2025-02-05
Latest Filing
partner: 2 acquirer: 1 investor: 1

Counterparties (Filed by ANVS)

4 relationships

Companies named in ANVS's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
ThinkEquity LLC — acquirer Representative of underwriters for the public offering of common stock and warrants. 2025-02-05 View
Oppenheimer & Co. Inc. OPY partner Entered into an Equity Distribution Agreement to serve as agent for an at-the-market offering program. 2024-12-11 View
ELOC Purchaser Capital Partners, LLC — investor Investor entering into a Common Stock Purchase Agreement to purchase up to 2,051,428 shares of common stock. 2024-04-26 View
ThinkEquity LLC — partner Sales agent for ATM Equity Offering 2023-04-03 View
Recent 8-K Filings (20)
Filing Date Description Type SEC
2026-08-14 Earnings Release; Exhibits View
2026-07-10 Other Events; Exhibits View
2026-06-17 Shareholder Vote; Exhibits View
2026-05-20 Material Agreement; Regulation FD; Exhibits Agreement View
2026-04-10 Material Agreement; Regulation FD; Exhibits Agreement View
2026-03-25 Officer/Director Change; Exhibits View
2026-03-16 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2026-02-12 Regulation FD Disclosure; Financial Statements and Exhibits View
2026-01-28 Regulation FD Disclosure; Financial Statements and Exhibits View
2025-11-13 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-10-28 Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits Agreement View
2025-10-14 Entry into Material Definitive Agreement; Regulation FD Disclosure; Other Events; Financial Statemen Agreement View
2025-09-29 Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits View
2025-08-15 Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits View
2025-08-12 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-06-23 Submission of Matters to a Vote of Security Holders; Financial Statements and Exhibits View
2025-06-20 Regulation FD Disclosure; Financial Statements and Exhibits View
2025-05-13 Results of Operations and Financial Condition; Departure/Election of Directors; Appointment of Offic View
2025-03-27 Notice of Delisting or Transfer; Departure/Election of Directors; Appointment of Officers; Regulatio View
2025-03-21 Results of Operations and Financial Condition; Financial Statements and Exhibits View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms